Usuda, Keisuke
Kato, Takeshi
Tsuda, Toyonobu
Tada, Hayato
Niwa, Satoru
Usui, Soichiro
Sakata, Kenji
Hayashi, Kenshi
Furusho, Hiroshi
Kawashiri, Masaaki
Takamura, Masayuki
Otsuka, Takayuki
Suzuki, Shinya
Hirata, Akio
Murakami, Masato
Takami, Mitsuru
Kimura, Masaomi
Fukaya, Hidehira
Nakahara, Shiro
Shimizu, Wataru
Iwasaki, Yu-ki
Hayashi, Hiroshi
Harada, Tomoo
Nakajima, Ikutaro
Okumura, Ken
Koyama, Junjiroh
Tokuda, Michifumi
Yamane, Teiichi
Momiyama, Yukihiko
Tanimoto, Kojiro
Soejima, Kyoko
Nonoguchi, Noriko
Ejima, Koichiro
Hagiwara, Nobuhisa
Harada, Masahide
Sonoda, Kazumasa
Inoue, Masaru
Kumagai, Koji
Hayashi, Hidemori
Satomi, Kazuhiro
Yazaki, Yoshinao
Watari, Yuji
Arai, Masaru
Watanabe, Ryuta
Yokoyama, Katsuaki
Matsumoto, Naoya
Nagashima, Koichi
Okumura, Yasuo
,
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 9 February 2021
Accepted: 13 August 2021
First Online: 15 September 2021
Declarations
:
: The following authors have potential conflicts of interest: T.K. received a research grant from Daiichi-Sankyo, and lecture fees from Bristol-Myers Squibb, Daiichi-Sankyo and Nippon Boehringer Ingelheim, and honoraria for writing promotional material for Bristol-Myers Squibb. S.S. received research funding from Daiichi-Sankyo and Mitsubishi-Tanabe. A.H. accepted remuneration from Nippon Boehringer Ingelheim, Bayer Healthcare, Bristol-Myers Squibb, Daiichi-Sankyo. M. Kimura accepted remuneration from Johnson & Johnson K.K., Medtronic Japan, Bayer Healthcare. H. Fukaya received lecture fees from Nippon Boehringer Ingelheim and Daiichi-Sankyo. S. Nakahara received lecture fees from Bayer Healthcare, Daiichi-Sankyo, Bristol-Meyers Squibb, Pfizer Japan, and Nippon Boehringer Ingelheim. W.S. received research funding from Bristol–Myers Squibb, Daiichi-Sankyo, and Nippon Boehringer Ingelheim, and patent royalties/licensing fees from Daiichi-Sankyo, Pfizer Japan, Bristol-Myers Squibb, Bayer Healthcare, and Nippon Boehringer Ingelheim. T.H. serves as a consultant to Medtronic Japan and has received lecture fees from Daiichi-Sankyo. I.N. received a scholarship from the Japanese Heart Rhythm Society and speaking honoraria from Medtronic Japan. K.O. received remuneration from Nippon Boehringer Ingelheim, Daiichi-Sankyo, Johnson & Johnson, and Medtronic Japan. M. Tokuda serves as a consultant to Medtronic Japan. T.Y. received lecture fees from Daiichi-Sankyo and Abbott Medical Japan. K.T. received lecture fees from Daiichi-Sankyo, Nippon Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer Japan, Bayer Healthcare. K. Soejima received research funding from Daiichi-Sankyo and Nippon Boehringer Ingelheim, and accepted remuneration from Medtronic Japan, Jonson & Jonson, and Abbott Medical Japan. N.H. accepted remuneration from Nippon Boehringer Ingelheim, Bristol-Myers Squibb, Bayer Healthcare, and research funding from Bayer Healthcare, Nippon Boehringer Ingelheim, Daiichi-Sankyo. M.H. received lecture fee from Nippon Boehringer Ingelheim, Daiichi-Sankyo, and Johnson & Johnson. K. Satomi and Y.Y. received research funding from BIOTRONIK Japan. N.M. received research funding from Daiichi-Sankyo. Y.O. received research funding from Bayer Healthcare, Daiichi-Sankyo, Bristol-Meyers Squibb, Nippon Boehringer Ingelheim, Pfizer Japan, TORAY, and Boston Scientific Japan and has accepted remuneration from Bayer Healthcare, Daiichi-Sankyo, and Bristol-Meyers Squibb. Other authors have no conflicts of interest.
: The protocol of this study was approved by Institutional Review Board of Nihon University Itabashi Hospital (RK-161213–6) along with the Institutional Review Boards of all participating institutions.